SARS is classified as a highly pathogenic viral respiratory condition triggered by SARS-CoV-1, distinguished from later coronavirus variants [1]. It denotes the inaugural human epidemic caused by a coronavirus, characterized by rapid cross-border dissemination following its identification in early 2003 [1][2]. The etiologic agent operates primarily through respiratory routes, necessitating specialized epidemiological tracking and clinical management frameworks [1].
Disease overview
SARS
传染性非典型肺炎
Evidence-backed informationEN 6/7 applicable sections · ZH 5/7 applicable sectionsUpdated Sep 3, 2026
Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by SARS-coronavirus-1, representing the first documented coronavirus epidemic in humans [1][2]. Initial cases emerged in Guangdong province, China, in late 2002 before spreading internationally via air travel [3][1]. The outbreak was ultimately contained through coordinated global health responses and strict public health measures [1][2]. Preparedness efforts continue to prioritize vaccine stockpiling and containment protocols due to the pathogen's high lethality and re-emergence potential [3][2].
Read the full clinical and epidemiological profile7
SARS is a viral respiratory illness with an incubation period that is typically 2–7 days, but may extend to 10 days [1]. The earliest recognized presentation in the international spread of the outbreak involved pneumonia-like respiratory symptoms severe enough to cause death in an index patient and to infect multiple medical staff despite basic hospital precautions, illustrating the disease's capacity to produce pronounced lower-respiratory and systemic illness [3]. During the 2003 outbreak aboard an Air China flight, a 72-year-old patient with SARS infected multiple people in a confined aircraft setting, resulting in multiple fatalities, underscoring the potential for severe clinical outcomes [3].
The index outbreak originated in Guangdong province during November 2002, with delayed international reporting initially impeding containment efforts [3][1]. Subsequent global dissemination reached twenty-eight nations, heavily facilitated by international aviation networks [1]. Epidemiological analyses indicate a basic reproduction number between 1.1 and 4.59, with superspreading events accounting for the vast majority of transmission chains [2].
Primary propagation occurs via airborne dispersal of small infectious respiratory particles generated by symptomatic individuals [1]. Indirect transmission may also occur when susceptible persons contact surfaces previously contaminated by respiratory secretions from infected hosts [1]. Acquisition risk is substantially elevated among healthcare personnel and individuals maintaining close physical proximity to confirmed cases [2]. Clinical mitigation requires rigorous isolation protocols alongside droplet and contact precautions utilizing personal protective equipment [3].
English source text only
Clinical severity and mortality risks are predominantly concentrated among older adults and individuals harboring underlying comorbidities [2]. Occupational exposure significantly elevates acquisition probability for medical staff and persons maintaining close contact with infected individuals [2].
Prevention of SARS relies on early detection combined with strict clinical isolation of suspected cases, alongside droplet and contact precautions through the use of personal protective equipment in hospital settings [3]. Contact tracing and quarantine of individuals who have been exposed to infected persons are effective measures for limiting community spread [3]. The original outbreak was ultimately controlled through public health interventions rather than vaccination; vaccines against SARS-CoV-1 were developed and stockpiled but were not deployed because public health measures ended the outbreak [3].
- 1World Health Organization. Severe Acute Respiratory Syndrome (SARS) [Internet]. cited 1 Sept 2026.Available from: https://www.who.int/health-topics/severe-acute-respiratory-syndrome
- 2Morgenstern C et al. Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review. Lancet Microbe. 2025 Sep. PMID: 40713974. doi: 10.1016/j.lanmic.2025.101144.PubMed: https://pubmed.ncbi.nlm.nih.gov/40713974/
- 3Wikipedia contributors. SARS - Wikipedia [Internet]. Wikipedia. cited 3 Sept 2026.Available from: https://en.wikipedia.org/wiki/SARS
- U04
- 1D65
Coverage
Reporting countries and regions
Trends by reporting country
Monthly patterns over time
Research Radar
Recent related research
Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant
Vaccine
Timing, Titre, and Host Determinants of Convalescent Plasma Efficacy in COVID-19: A Systematic Review With Design-Stratified Narrative Synthesis.
Reviews in medical virology
Factors that impact on healthcare workers' adherence with infection prevention and control (IPC) guidelines for COVID-19: a qualitative evidence synthesis.
The Cochrane database of systematic reviews
Convalescent Plasma Restores Viral Clearance After Anti-Spike Monoclonal Antibody Failure in Immunocompromised COVID-19 Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.
Reviews in medical virology
Mixing versus matching booster vaccines: A longitudinal humoral immune kinetics against Omicron in a Malaysian cohort
International Journal of Infectious Diseases
Showing 5 of 243 related publications.
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Data access
Page dataset index with source links and update metadata.
Official sourcesAuthority, cadence, notes36
Canada PHAC CNDSS Annual
Canada
Canada is the national jurisdiction; subdivision feeds are registered separately.
China CDC Weekly
China
Monthly notifiable infectious disease reports published by China CDC.
National Disease Control and Prevention Administration
China
Official China public health bulletin and query portal.
PubMed
China
Biomedical literature discovery feed used as supplementary context.
Public Health Science Data Center
Anhui, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Anhui, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Chongqing, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Chongqing, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Guangdong, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Guangdong, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Gansu, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Gansu, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Henan, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Henan, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Jiangsu, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Jiangsu, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Sichuan, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Sichuan, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Shandong, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Shandong, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Shanghai, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Shanghai, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Xinjiang, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Xinjiang, China
Province-level statutory infectious disease report published by the responsible health authority.
Public Health Science Data Center
Zhejiang, China
Chinese province-level historical monthly observations; this higher-priority source overlays overlapping official monthly reports.
Provincial statutory infectious disease monthly report
Zhejiang, China
Province-level statutory infectious disease report published by the responsible health authority.
Hong Kong, China CHP Notifiable Diseases
Hong Kong, China
Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals
Iceland Directorate of Health Annual Dashboard
Iceland
National annual case notifications by disease. Published values can be revised retrospectively and remain annual period totals.
Iceland Directorate of Health STI Dashboard
Iceland
Monthly STI diagnosis facts from laboratory and registry surveillance; the official dashboard is published on a quarterly schedule.
Iceland Directorate of Health Respiratory Dashboard
Iceland
ISO-week respiratory diagnosis counts. Hospitalizations, samples, and vaccination indicators are separate measures and are not counted as diagnoses.
Iceland Directorate of Health Historical Registry
Iceland
Historical official registry tables for 1997–2021, with annual totals and disease-specific monthly notification facts retained at source grain.
Iceland Directorate of Health Legacy ICD Monthly
Iceland
Historical Saga EHR ICD encounter counts for 1997–2020. This clinical measure is non-comparable with registry notifications and is kept separate.
JP NIID Weekly
Japan
Japan weekly infectious disease surveillance via NIID/JIHS.
Korea KDCA EID
South Korea
Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.
Singapore CDA Weekly Infectious Diseases Bulletin
Singapore
Singapore national weekly case notifications, combining the official data.gov.sg 2012–2022 CSV history with CDA annual workbooks from 2023 onward; 2023 weekly PDFs are retained as a source fallback.
Taiwan, China CDC NIDSS
Taiwan, China
Taiwan, China monthly notifiable infectious disease open-data CSV feed.